Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised

Neurology

Volumn 79, Issue 21, 2012, Pages 2125-2132

  Tan, Ik L ^a   McArthur, Justin C ^a   Venkatesan, Arun ^a   Nath, Avindra ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX ENCEPHALITIS; HISTOPATHOLOGY; HUMAN; IMMUNOCOMPROMISED PATIENT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MORTALITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84870776551     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182752ceb     Document Type: Article

References (34)

1. Granerod J, Ambrose HE, Davies NW, et al. Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 2010;10:835-844.
2. Hjalmarsson A, Blomqvist P, Skoldenberg B. Herpes simplex encephalitis in Sweden, 1990-2001: incidence, morbidity, and mortality. Clin Infect Dis 2007;45:875-880.
3. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006;71:141-148.
4. Rozenberg F, Deback C, Agut H. Herpes simplex encephalitis: from virus to therapy. Infect Disord Drug Targets 2011;11:235-250.
5. Whitley RJ, Alford CA, Hirsch MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986;314:144-149.
6. Riera-Mestre A, Gubieras L, Martinez-Yelamos S, Cabellos C, Fernandez-Viladrich P. Adult herpes simplex encephalitis: fifteen years' experience. Enferm Infecc Microbiol Clin 2009;27:143-147.
7. Schiff D, Rosenblum MK. Herpes simplex encephalitis (HSE) and the immunocompromised: a clinical and autopsy study of HSE in the settings of cancer and human immunodeficiency virus-type 1 infection. Hum Pathol 1998;29: 215-222.
8. McGrath N, Anderson NE, Croxson MC, Powell KF. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J Neurol Neurosurg Psychiatry 1997;63:321-326.
9. Raschilas F, Wolff M, Delatour F, et al. Outcome of and prognostic factors for herpes simplex encephalitis in adult patients: results of a multicenter study. Clin Infect Dis 2002;35:254-260.
10. Domingues RB, Tsanaclis AM, Pannuti CS, Mayo MS, Lakeman FD. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples. Clin Infect Dis 1997;25:86-91.
11. Whitley RJ, Soong SJ, Linneman C Jr., Liu C, Pazin G, Alford CA. Herpes simplex encephalitis: clinical assessment. JAMA 1982;247:317-320.
12. Baringer JR, Pisani P. Herpes simplex virus genomes in human nervous system tissue analyzed by polymerase chain reaction. Ann Neurol 1994;36:823-829.
13. Sanders VJ, Waddell AE, Felisan SL, Li X, Conrad AJ, Tourtellotte WW. Herpes simplex virus in postmortem multiple sclerosis brain tissue. Arch Neurol 1996;53: 125-133.
14. Koudriavtseva T, Onesti E, Tonachella R, Pelagalli L, Vidiri A, Jandolo B. Fatal herpetic encephalitis during brain radiotherapy in a cerebral metastasized breast cancer patient. J Neurooncol 2010;100: 137-140.
15. Schlageter N, Jubelt B, Vick NA. Herpes simplex encephalitis without CSF leukocytosis. Arch Neurol 1984;41: 1007-1008.
16. Zhou L, Li J, Wang X, et al. IL-29/IL-28A suppress HSV-1 infection of human NT2-N neurons. J Neurovirol 2011; 17:212-219.
17. Johnson M, Valyi-Nagy T. Expanding the clinicopathologic spectrum of herpes simplex encephalitis. Hum Pathol 1998;29:207-210.
18. Lach B, Atack E. Disseminated hemorrhagic leukoencephalomyelitis with localized herpes simplex brain stem infection. Acta Neuropathol 1988;75:354-361.
19. Martin JR, Holt RK, Webster HD. Herpes-simplex-related antigen in human demyelinative disease and encephalitis. Acta Neuropathol 1988;76:325-337.
20. Fodor PA, Levin MJ, Weinberg A, Sandberg E, Sylman J, Tyler KL. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology 1998;51:554-559.
21. Levy RM, Bredesen DE, Rosenblum ML. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985;62:475-495.
22. Wasay M, Mekan SF, Khelaeni B, et al. Extra temporal involvement in herpes simplex encephalitis. Eur J Neurol 2005;12:475-479.
23. Auyeung P, Dunn A. Atypical case of herpes simplex encephalitis. Intern Med J 2008;38:294-295.
24. Price R, Chernik NL, Horta-Barbosa L, Posner JB. Herpes simplex encephalitis in an anergic patient. Am J Med 1973;54:222-228.
25. Bordes J, Kenane N, Meaudre E, et al. A case of atypical and fatal herpes simplex encephalitis in a severe burn patient. Burns 2009;35:590-593.
26. Laskin OL, Stahl-Bayliss CM, Morgello S. Concomitant herpes simplex virus type 1 and cytomegalovirus ventriculoencephalitis in acquired immunodeficiency syndrome. Arch Neurol 1987;44:843-847.
27. Skoldenberg B. Herpes simplex encephalitis. Scand J Infect Dis Suppl 1996;100:8-13.
28. Manz HJ, Phillips TM, McCullough DC. Herpes simplex type 2 encephalitis concurrent with known cerebral metastases. Acta Neuropathol 1979;47:237-240.
29. Casrouge A, Zhang SY, Eidenschenk C, et al. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 2006;314:308-312.
30. Zhang SY, Jouanguy E, Ugolini S, et al. TLR3 deficiency in patients with herpes simplex encephalitis. Science 2007; 317:1522-1527.
31. Lima GK, Zolini GP, Mansur DS, et al. Toll-like receptor (TLR) 2 and TLR9 expressed in trigeminal ganglia are critical to viral control during herpes simplex virus 1 infection. Am J Pathol 2010;177:2433-2445.
32. Bradford RD, Pettit AC, Wright PW, et al. Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis 2009;49:924-927.
33. Cohen JA, Barkhof F, Comi G, et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med 2010;362:402-415.
34. Graber JJ, Rosenblum MK, DeAngelis LM. Herpes simplex encephalitis in patients with cancer. J Neurooncol 2011;105:415-421.